BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35181630)

  • 1.
    Dasgupta A; Khalil S; Paddock T; Wahed A
    Ann Clin Lab Sci; 2022 Jan; 52(1):161-163. PubMed ID: 35181630
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Ghosh A; Russell A; Dasgupta A
    Ann Clin Lab Sci; 2022 May; 52(3):504-506. PubMed ID: 35777806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Biotin on Cardiac Troponin I and High Sensitivity Cardiac Troponin I Assays on Vista 1500 and ADVIA Centaur Analyzer.
    Dasgupta A; Khalil S
    Ann Clin Lab Sci; 2021 Jan; 51(1):102-105. PubMed ID: 33653787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Risk for Interference by Circulating Biotin in Samples Received for High Sensitivity Troponin-T, Thyrotropin, and for Prostate Specific Antigen Testing by Immunoassays.
    Nguyen KQN; Langevin R; Fankhauser K; Hashim IA
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotin at High Concentration Interferes with the LOCI Digoxin Assay but the PETINIA Phenytoin Assay Is Not Affected.
    Rodriguez JJ; Acosta F; Bourgeois L; Dasgupta A
    Ann Clin Lab Sci; 2018 Mar; 48(2):164-167. PubMed ID: 29678842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin interference in TSH, FT4, and FT3 assays based on the LOCI technology: Identifying interference by dilution.
    Dasgupta A; Bourgeois L
    J Clin Lab Anal; 2019 Feb; 33(2):e22667. PubMed ID: 30221397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays.
    Trambas C; Lu Z; Yen T; Sikaris K
    Ann Clin Biochem; 2018 Mar; 55(2):205-215. PubMed ID: 28875734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive assessment of biotin interference in immunoassays.
    Li J; Wagar EA; Meng QH
    Clin Chim Acta; 2018 Dec; 487():293-298. PubMed ID: 30296442
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Dasgupta A; Sengupta TK; Trinh EM; Russell A
    Ann Clin Lab Sci; 2022 Mar; 52(2):336-338. PubMed ID: 35414513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigating biotin interference in two Roche immunoassays by premixing biotinylated capturing molecules with streptavidin coated beads.
    Yang J; Wiencek JR
    Clin Chim Acta; 2020 Jun; 505():130-135. PubMed ID: 32084383
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    McBride M; Dasgupta A
    Ann Clin Lab Sci; 2023 May; 53(3):482-484. PubMed ID: 37437939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum biotin interference: A troublemaker in hormone immunoassays.
    Öncül Ü; Eminoğlu FT; Köse E; Doğan Ö; Özsu E; Aycan Z
    Clin Biochem; 2022 Jan; 99():97-102. PubMed ID: 34736903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Asian ginseng, Siberian ginseng, and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.
    Dasgupta A; Tso G; Wells A
    J Clin Lab Anal; 2008; 22(4):295-301. PubMed ID: 18623124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical risk assessment of biotin interference with a high-sensitivity cardiac troponin T assay.
    Mumma B; Diercks D; Twerenbold R; Valcour A; Ziegler A; Schützenmeister A; Kasapic D; Tran N
    Clin Chem Lab Med; 2020 Oct; 58(11):1931-1940. PubMed ID: 32804676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking Advantage of Assay Harmonization, Biotin Interference in the LOCI Digoxin Assay Could Be Eliminated by Using the ADVIA Centaur Digoxin Assay.
    Dasgupta A; Belousova T; Bourgeois L; Wahed A
    Ann Clin Lab Sci; 2018 Sep; 48(5):614-617. PubMed ID: 30373866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin immunoassay interference: A UK-based prevalence study.
    Sanders A; Gama R; Ashby H; Mohammed P
    Ann Clin Biochem; 2021 Jan; 58(1):66-69. PubMed ID: 32936669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center.
    Stieglitz HM; Korpi-Steiner N
    Clin Biochem; 2020 Jan; 75():53-61. PubMed ID: 31677994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotin interference in immunoassay: a review for the laboratory scientist.
    Avery G
    Ann Clin Biochem; 2019 Jul; 56(4):424-430. PubMed ID: 31023057
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of biotin on currently used Beckman thyroglobulin assay and newly reformulated thyroglobulin assay not affected by biotin.
    Countryman B; McBride M; McCracken T; Dasgupta A
    Am J Clin Pathol; 2024 Apr; ():. PubMed ID: 38682538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of detectable biotin in The Netherlands in relation to risk on immunoassay interference.
    IJpelaar A; Beijers A; van Daal H; van den Ouweland JMW
    Clin Biochem; 2020 Sep; 83():78-80. PubMed ID: 32473152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.